Tempus AI Inc. (NASDAQ:TEM) reported second-quarter financial results Friday. The AI-focused precision medicine and patient ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

The stock of Tempus AI (NASDAQ: TEM) gave back some of its gains after surging early in Friday's trading, but it still ended ...

Tempus AI (NASDAQ:TEM) stock sees a 9% pre-market gain as the company raises its 2025 revenue outlook amid strong Q2 ...

In trading on the Nasdaq stock market as of 1:17 p.m. Central, Tempus' stock price was trading at $60.65, up 3.2% from the ...

Although shares have retreated from their all-time high, those who bought shares one year ago are still looking at growth in ...

These 10 stocks could mint the next wave of millionaires › Tempus AI (NASDAQ:TEM), a technology company that applies artificial intelligence to precision diagnostics and healthcare data, reported its ...

Analysts expect the Chicago, Illinois-based company to report a quarterly loss at 25 cents per share, versus a year-ago loss ...

Discover Tempus AI's impressive Q2 2025 results: 89.6% revenue growth, stronger guidance, robust data deals, and strides toward breakeven.

Tempus (TEM) delivered earnings and revenue surprises of +4.35% and +5.12%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

CHICAGO (AP) — CHICAGO (AP) — Tempus AI Inc. (TEM) on Friday reported a loss of $42.8 million in its second quarter. The Chicago-based company said it had a loss of 25 cents per share. Losses, ...

Investing.com -- Tempus AI (NASDAQ: TEM) surged 9% in premarket trading Friday after the genetic testing firm reported a ...